Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 35% ± 19% | |
GABAergic neuron | 5 studies | 36% ± 19% | |
endothelial cell | 4 studies | 23% ± 7% | |
interneuron | 4 studies | 32% ± 20% | |
adipocyte | 3 studies | 17% ± 1% | |
type I pneumocyte | 3 studies | 21% ± 4% | |
macrophage | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 27% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1048.01 | 89 / 89 | 96% | 26.62 | 868 / 901 |
brain | 96% | 2295.70 | 2545 / 2642 | 94% | 16.55 | 665 / 705 |
pancreas | 97% | 379.41 | 317 / 328 | 65% | 3.55 | 116 / 178 |
lung | 94% | 552.66 | 546 / 578 | 58% | 6.38 | 675 / 1155 |
prostate | 85% | 207.52 | 209 / 245 | 57% | 2.33 | 286 / 502 |
adrenal gland | 60% | 95.67 | 155 / 258 | 58% | 5.16 | 133 / 230 |
ovary | 28% | 40.31 | 51 / 180 | 76% | 7.35 | 325 / 430 |
uterus | 82% | 164.81 | 139 / 170 | 14% | 0.63 | 63 / 459 |
intestine | 61% | 82.92 | 588 / 966 | 33% | 1.60 | 175 / 527 |
thymus | 79% | 117.64 | 516 / 653 | 9% | 0.32 | 55 / 605 |
stomach | 37% | 51.33 | 133 / 359 | 44% | 2.34 | 127 / 286 |
esophagus | 43% | 65.10 | 619 / 1445 | 36% | 1.74 | 65 / 183 |
breast | 55% | 91.94 | 253 / 459 | 20% | 1.23 | 219 / 1118 |
adipose | 51% | 261.01 | 611 / 1204 | 0% | 0 | 0 / 0 |
bladder | 29% | 31.38 | 6 / 21 | 19% | 1.81 | 96 / 504 |
liver | 10% | 13.71 | 22 / 226 | 29% | 3.00 | 116 / 406 |
skin | 31% | 31.70 | 552 / 1809 | 2% | 0.09 | 8 / 472 |
blood vessel | 32% | 44.63 | 422 / 1335 | 0% | 0 | 0 / 0 |
heart | 12% | 19.98 | 107 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.39 | 4 / 45 |
peripheral blood | 8% | 8.62 | 76 / 929 | 0% | 0 | 0 / 0 |
spleen | 7% | 6.82 | 17 / 241 | 0% | 0 | 0 / 0 |
muscle | 2% | 2.09 | 14 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010001 | Biological process | glial cell differentiation |
GO_0098742 | Biological process | cell-cell adhesion via plasma-membrane adhesion molecules |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0030574 | Biological process | collagen catabolic process |
GO_0097150 | Biological process | neuronal stem cell population maintenance |
GO_0050965 | Biological process | detection of temperature stimulus involved in sensory perception of pain |
GO_0006508 | Biological process | proteolysis |
GO_0044331 | Biological process | cell-cell adhesion mediated by cadherin |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0031012 | Cellular component | extracellular matrix |
GO_0045296 | Molecular function | cadherin binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0008047 | Molecular function | enzyme activator activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | MMP24 |
Protein name | Alternative protein MMP24 Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24] MMP24 protein |
Synonyms | MT5MMP |
Description | FUNCTION: Metalloprotease that mediates cleavage of N-cadherin (CDH2) and acts as a regulator of neuro-immune interactions and neural stem cell quiescence. Involved in cell-cell interactions between nociceptive neurites and mast cells, possibly by mediating cleavage of CDH2, thereby acting as a mediator of peripheral thermal nociception and inflammatory hyperalgesia. Key regulator of neural stem cells quiescence by mediating cleavage of CDH2, affecting CDH2-mediated anchorage of neural stem cells to ependymocytes in the adult subependymal zone, leading to modulate their quiescence. May play a role in axonal growth. Able to activate progelatinase A. May also be a proteoglycanase involved in degradation of proteoglycans, such as dermatan sulfate and chondroitin sulfate proteoglycans. Cleaves partially fibronectin, but not collagen type I, nor laminin (By similarity). . |
Accessions | ENST00000246186.8 L8E8C1 Q86VV6 Q9Y5R2 |